CMC is a proud recipient of a $20,000 Genentech Foundation grant which will be used in 2017 to provide integrative cancer care to our clients with advanced cancer.
Genentech is committed to being a strong corporate citizen, and the Genentech Foundation is one of the most important ways they give back to local communities. Launched in 2002, the Foundation is charged with identifying and supporting select organizations whose missions and outreach align with their funding priorities of health education, patient support and community support.